Dosage form: Syrup.
Pharmacotherapeutic group: General tonic agent.
Composition (per 100 ml):
Active substances: St. John's Wort herb (Hypericum perforatum) – 11.2 g, Senna leaves (Cassia acutifolia) – 7.4 g, Rosehip fruits (Rosa cinnamomea) – 7.4 g, Red Beet roots (Beta vulgaris) – 11.2 g.
Excipients: Sugar, lemon oil, glycerin, propylene glycol, potassium sorbate, water.
Neoimmune syrup contains a complex of biologically active substances: Anthracene derivatives (hypericin, pseudohypericin, gluco-aloe-emodin, glucorein), flavonoids (hyperoside, quercetin, rutin, isorhamnetin, kaempferol), vitamins (C, B1, B2, P, PP, K, E), carotenoids, mineral salts, organic acids (citric, malic), fatty oils, and pectin substances.
Pharmacological action: Experimental and clinical studies have established that the preparation possesses immunostimulatory action, enhancing the generation of antibody-producing cells and antibody production. It exhibits immunocorrective properties across various models of immunosuppression, including so-called "ecological immunodeficiency," making its use as an immunomodulator advisable in diseases accompanied by reduced humoral immunity.
Indications: Used in complex therapy as an adjuvant treatment for:
- Acute and chronic infectious diseases (influenza, pneumonia, hepatitis, cholecystitis, etc.);
- Postoperative period;
- Prolonged physical and mental fatigue;
- Exhaustion associated with insomnia and psycho-emotional stress;
- Exposure to adverse environmental factors;
- General weakness and malaise.
Contraindications: Hypersensitivity to any component of the preparation.
Dosage and administration: Administered orally after meals. The syrup may be diluted in a small amount of water.
- Adults: 5–10 ml syrup (1–2 teaspoons) 3 times daily.
- Children aged 1 to 3 years: 2.5 ml syrup (1/2 teaspoon) once daily.
- Children aged 3 to 6 years: 5 ml syrup (1 teaspoon) once daily or 2.5 ml syrup (1/2 teaspoon) twice daily.
- Children aged 6 to 10 years: 5 ml syrup (1 teaspoon) twice daily.
- Children aged 10 to 14 years: 5 ml syrup (1 teaspoon) 3 times daily.
The duration of the treatment course is 1 month. If necessary, a repeated course may be administered following a 2-week break.
In case of a missed dose, the subsequent dose should be taken according to the original schedule.
Side effects: Prolonged use may cause an increase in blood pressure.
Pregnancy and lactation: Has not been studied.
Drug interactions: Has no effect.
Effects on ability to drive and use machines: Has no effect.
Overdose: No cases of overdose have been reported.
Packaging:
Primary packaging: 100 ml syrup in a dark orange polymer bottle.
Secondary packaging: 1 bottle in a cardboard box together with the instruction leaflet.
Shelf life: 2 years.
The preparation must not be used after the expiry date or if defects are detected upon visual inspection.
Prescription status: Group III pharmaceutical product, non-prescription (OTC).
Storage conditions: Store at a temperature of 15–25°C, protected from light, and out of reach of children.
Manufacturer: "Neopharm" LLC,
12th km David Agmashenebeli Alley, Tbilisi, Georgia.
Tel/Fax: +995 (032) 259-57-90, 259-64-46.
| ნეოდერმი ანტიასაკობრივი 50+ | ნეოდერმი ანტიასაკობრივი 50+ |
|---|
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Reviews
There are no reviews yet.